# FDA Inspection 1178621 - Childrens Oncology Group - August 19, 2022

Source: https://www.keypedia.com/records/fda_inspections/childrens-oncology-group/c5ec5f19-69b2-471b-8b76-cb72c1f86e58
Source feed: FDA_Inspections

> FDA Inspection 1178621 for Childrens Oncology Group on August 19, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1178621
- Company Name: Childrens Oncology Group
- Inspection Date: 2022-08-19
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1152384 - 2021-09-17](https://www.keypedia.com/records/fda_inspections/childrens-oncology-group/9a1081a3-287f-4f3a-b3b5-3f496f181a69)

Company: https://www.keypedia.com/companies/childrens-oncology-group/613a8bb7-5ca9-4ede-839f-51fc0492fe06

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c